The Global Hyperkalemia Drugs Market Size Was Estimated at USD 1.13 Billion in 2024 and is Projected to Reach USD 4.78 Billion by 2035, Growing at a CAGR of 14.01% from 2025 to 2035. Growing awareness of the risks of hyperkalemia, the incidence of chronic renal disease and heart failure,